Pronounced State Level Disparities in Medicaid Prescribing of Buprenorphine for Opioid Use Disorder (2019-2020)

CONCLUSIONS: The COVID-19 pandemic exacerbated state-level disparities in buprenorphine prescribing for OUD among Medicaid patients. Legislation expanding buprenorphine waivered providers and Medicaid expansion may have contributed to the statistically significant changes in state buprenorphine prescriptions.PMID:37650858 | DOI:10.15288/jsad.22-00373

Source: Journal of Studies on Alcohol and Drugs - August 31, 2023 Category: Addiction Authors: Sydney R Dana Stephanie D Nichols Kenneth L McCall Brian J Piper Source Type: research